Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.

A new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond ...

As global temperatures rise, Cold Spring Harbor Laboratory (CSHL) scientists work to grow stronger, more resilient crops. Yet ...

CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...

The genetically engineered food is also protein packed and sustainable, say scientists. Chinese researchers used gene-editing ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

The "Mice Model Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering.The mice model market is experiencing robust growth, with projected expansion from USD 1.61 ...

Biotech startup CrisprBits uses CRISPR-based techniques to change the shape of diagnostics by decoding genetic sequencing ...

The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...